Latest blood clots Stories
NEW YORK, Jan. 31, 2013 /PRNewswire/ -- The Lupus Research Institute (LRI) - world's leading supporter of innovative research in lupus -- today awards $3.6 million in Novel Research Grants to allow 12 investigators to pursue ground-breaking studies with potential for transformative results. The $300,000 grants provide scientists with the resources to devote their talent to lupus research for three years. In just its first decade of service, the LRI has awarded more than $40 million...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) January 24, 2013 The prescription drug resource center DrugRisk.com is alerting women who have used the vaginal ring contraceptive NuvaRing of new information added to the site showing trials are scheduled to begin this year for those claiming they suffered blood clots from the devices. The mission of...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) January 18, 2013 The prescription drug resource center DrugRisk.com has added new information for those patients using the vaginal ring contraceptive NuvaRing showing, while the device has been linked to blood clots in the past, the risk may be even higher for women suffering migraines. The mission of...
SAN DIEGO, Jan. 15, 2013 /PRNewswire-USNewswire/ -- Women who have migraines with aura, which are often visual disturbances such as flashing lights, may be more likely to have problems with their heart and blood vessels, and those on newer contraceptives may be at higher risk for blood clots, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The first study showed that...
CRESSKILL, N.J., Jan. 11, 2013 /PRNewswire/ -- The trial date for over 1,000 NuvaRing lawsuits is being extended, feeding rumors that the vaginal ring contraceptive's manufacturer, Merck, may be ready to enter settlement negotiations. The lawsuits allege that NuvaRing caused serious side effects, including blood clots, deep vein thrombosis, pulmonary embolism, heart attacks, strokes, and wrongful death. The multidistrict litigation before Rodney W. Sippel of the U.S. District Court,...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) January 04, 2013 The prescription drug resource center DrugRisk.com is advising women who use the vaginal ring contraceptive NuvaRing that, amid warnings about risks of blood clots and news of injury claims filed by those affected, Merck has reported reduced sales of the devices. The goal of DrugRisk is...
OTTAWA, Dec. 21, 2012 /CNW/ - The issue: Health Canada is advising health care professionals and the public that, based on new information, the blood-thinning drug Pradaxa is not to be used in patients with artificial heart valves (also known as prosthetic heart valves) due to the risk of strokes, bleeding, heart attacks, and blood clots forming on the artificial heart valves. Who is affected: Patients who are taking Pradaxa and have an artificial heart valve....
OTTAWA, Dec. 21, 2012 /CNW/ - The issue: Health Canada is advising health care professionals and the public that, based on new information, the blood-thinning drug Pradaxa is not to be used in patients with artificial heart valves (also known as prosthetic heart valves) due to the risk of strokes, bleeding, heart attacks, and blood clots forming on the artificial heart valves. Who is affected: Patients who are taking Pradaxa and have an artificial heart valve....
Blau, Brown & Leonard, LLC announce that they have lawyers standing by Toll Free 1-(800) YAZ-0287 if They Took Yaz, Yasmin, BeYaz or Ocella and Suffered Pulmonary Embolisms, DVT's or Stroke; Settlements Continue to Grow New York, NY (PRWEB) December 13, 2012 Sales of Yaz and Yasmin continue to surge according to Bayer's thrid quarter shareholder release. http://www.stockholders-newsletter-q3-2012.bayer.com/en/bayer-healthcare.aspx Blau, Brown & Leonard, LLC settlements...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) December 07, 2012 The DrugRisk Resource Center, a patient awareness group, is alerting women prescribed the contraceptive NuvaRing that experts have linked the devices to blood clots and the FDA has received thousands of reports of complications among users. According to the Adverse Events Report on...
